SARIDAŞ, F. Et Al. 2024. Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up. Heliyon , vol.10, no.5 .

SARIDAŞ, F., MERCAN SARIDAŞ, F., KOÇ, E. R., & TURAN, Ö. F., (2024). Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up. Heliyon , vol.10, no.5.

SARIDAŞ, FURKAN Et Al. "Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up," Heliyon , vol.10, no.5, 2024

SARIDAŞ, FURKAN Et Al. "Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up." Heliyon , vol.10, no.5, 2024

SARIDAŞ, F. Et Al. (2024) . "Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up." Heliyon , vol.10, no.5.

@article{article, author={FURKAN SARIDAŞ Et Al. }, title={Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up}, journal={Heliyon}, year=2024}